Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP921174.RAh4mTI-2-tyHBu8q4uvG5piFi8JYLxkMyprLjvjquYto130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP921174.RAh4mTI-2-tyHBu8q4uvG5piFi8JYLxkMyprLjvjquYto130_assertion type Assertion NP921174.RAh4mTI-2-tyHBu8q4uvG5piFi8JYLxkMyprLjvjquYto130_head.
- NP921174.RAh4mTI-2-tyHBu8q4uvG5piFi8JYLxkMyprLjvjquYto130_assertion description "[Among other clinical and genetic factors, polymorphisms of CYP2B6 genes that interfere with cyclophosphamide metabolism were associated with OM (recipient CYP2B6(*)4; P=0.0067), HC (recipient CYP2B6(*)2; P=0.03) and VOD (donor CYP2B6(*)6; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921174.RAh4mTI-2-tyHBu8q4uvG5piFi8JYLxkMyprLjvjquYto130_provenance.
- NP921174.RAh4mTI-2-tyHBu8q4uvG5piFi8JYLxkMyprLjvjquYto130_assertion evidence source_evidence_literature NP921174.RAh4mTI-2-tyHBu8q4uvG5piFi8JYLxkMyprLjvjquYto130_provenance.
- NP921174.RAh4mTI-2-tyHBu8q4uvG5piFi8JYLxkMyprLjvjquYto130_assertion SIO_000772 19005482 NP921174.RAh4mTI-2-tyHBu8q4uvG5piFi8JYLxkMyprLjvjquYto130_provenance.
- NP921174.RAh4mTI-2-tyHBu8q4uvG5piFi8JYLxkMyprLjvjquYto130_assertion wasDerivedFrom befree-20140225 NP921174.RAh4mTI-2-tyHBu8q4uvG5piFi8JYLxkMyprLjvjquYto130_provenance.
- NP921174.RAh4mTI-2-tyHBu8q4uvG5piFi8JYLxkMyprLjvjquYto130_assertion wasGeneratedBy ECO_0000203 NP921174.RAh4mTI-2-tyHBu8q4uvG5piFi8JYLxkMyprLjvjquYto130_provenance.